Lee-jen Chen

No. 92, Sec. 2, Zhongshan N. Rd
Zhongshan Dist, TPQ 10449, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Discontinuing Anti-VEGF Therapy in Patients with Neovascular Age-Related Macular Degeneration That Remains Inactive with Treatment at the Maximum Injection Interval.

Journal: Clinical ophthalmology (Auckland, N.Z.)

Published: December 11, 2025

Long-Term retrospective analysis of retinal pigment epithelium atrophy and secondary hyperplasia following verteporfin photodynamic therapy.

Long-Term retrospective analysis of retinal pigment epithelium atrophy and secondary hyperplasia following verteporfin photodynamic therapy.

Journal: Photodiagnosis and photodynamic therapy

Published: February 12, 2025

Systemic effects of anti-VEGF intravitreal injection in patients with age-related macular degeneration: A multi-institutional real-world study.

Systemic effects of anti-VEGF intravitreal injection in patients with age-related macular degeneration: A multi-institutional real-world study.

Journal: Indian journal of ophthalmology

Published: December 07, 2023

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients.

The Association of Intravitreal Injections of Different Anti-Vascular Endothelial Growth Factor with Systemic Outcomes in Diabetic Patients.

Journal: Journal of personalized medicine

Published: January 29, 2023

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor.

Systemic Outcomes of Intravitreal Injections of Dexamethasone and Anti-Vascular Endothelial Growth Factor.

Journal: Ophthalmology and therapy

Published: October 30, 2022

Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes.

Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes.

Journal: Eye (London, England)

Published: June 02, 2022

Retinal vasoproliferative tumor regression after intravitreal aflibercept.

Retinal vasoproliferative tumor regression after intravitreal aflibercept.

Journal: Taiwan journal of ophthalmology

Published: February 21, 2022

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan.

Optimal approaches and criteria to treat-and-extend regimen implementation for Neovascular age-related macular degeneration: experts consensus in Taiwan.

Journal: BMC ophthalmology

Published: June 01, 2021

Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy.

Clinical features of pachyvessels associated with polypoidal choroidal vasculopathy in chronic central serous chorioretinopathy.

Journal: Scientific reports

Published: April 09, 2021

Management of neovascular age-related macular degeneration: Taiwan expert consensus.

Management of neovascular age-related macular degeneration: Taiwan expert consensus.

Journal: Journal of the Formosan Medical Association = Taiwan yi zhi

Published: August 17, 2020

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy: The EVEREST II Randomized Clinical Trial.

Journal: JAMA ophthalmology

Published: July 17, 2020

Management of diabetic macular edema: experts' consensus in Taiwan.

Management of diabetic macular edema: experts' consensus in Taiwan.

Journal: Japanese journal of ophthalmology

Published: December 15, 2019

Showing 1-12 of 25

Last Updated: 09/26/2026